What medication can provide symptomatic relief in peripheral vascular disease (PVD)?

Cilostazol is the correct choice for providing symptomatic relief in peripheral vascular disease (PVD). This medication is a phosphodiesterase type 3 inhibitor that works by vasodilation and by inhibiting platelet aggregation. It improves blood flow to the extremities, which can alleviate the symptoms of claudication, a common manifestation in patients with PVD. By enhancing walking distance and reducing pain associated with activity, cilostazol directly addresses the symptoms that patients experience due to insufficient blood supply.

Other medications listed have different roles in cardiovascular health. Aspirin and clopidogrel are used primarily for their antiplatelet effects, aimed at reducing the risk of thromboembolic events, rather than providing symptomatic relief for claudication. Warfarin is an anticoagulant that helps prevent blood clots, but it does not improve blood flow or relieve symptoms associated with PVD. Thus, while all these medications play important roles in managing cardiovascular diseases, cilostazol specifically targets the symptomatic relief for patients suffering from PVD.